(Total Views: 576)
Posted On: 01/06/2022 2:47:23 PM
Post# of 153933
Question to ohm.
"We have topline data for NASH it has been sent to the FDA and U.S. and international pharmaceutical companies. They should release it immediately to the public."
Read More: https://investorshangout.com/post/view?id=631...z7HDmkW67H
__________
OK. Now can you explain what would be the purpose of sending this data from 20 patients (your data!) in the open 350 mg trial rather than sending top line data for our 700 mg phase 2 double-blind etc trial that Nader et al promised by Christmas? OK. Let it take some more time to calculate. But why not to wait?
Or it's like "What 700 mg trial"? What am I talking about?
"We have topline data for NASH it has been sent to the FDA and U.S. and international pharmaceutical companies. They should release it immediately to the public."
Read More: https://investorshangout.com/post/view?id=631...z7HDmkW67H
__________
OK. Now can you explain what would be the purpose of sending this data from 20 patients (your data!) in the open 350 mg trial rather than sending top line data for our 700 mg phase 2 double-blind etc trial that Nader et al promised by Christmas? OK. Let it take some more time to calculate. But why not to wait?
Or it's like "What 700 mg trial"? What am I talking about?
(1)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
